← Home / IMMUNOVANT, INC. (IMVT)
Stock Analysis
IMMUNOVANT, INC. (IMVT)
IMVT
IMVT · Market data
39.71 -3.36%
52W Range Position
95%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-12 19:57 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 41.09. Holding above 34.12 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
34.12
↗
Break Above
Confirmation improves above resistance.
41.09
🎯
Next Objective
Pattern-derived target if setup continues.
51.53
×
Thesis Break
Scenario weakens below invalidation.
Below 34.12
What's Driving IMVT?
📈 Technical recovery is improving
Momentum is Neutral. Watch 41.09 for confirmation and 34.12 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 34.12
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Bull Flag · Confirmed
Trigger
39.00
Target
46.51
Invalidation
37.51
Pattern
Triangle Compression / SYM / UP
State
Back Inside
Trigger
40.40
Target
51.53
Risk / Invalid
36.65
Compression
66%
◎
How to read this setup
Active technical structure detected. Use the chart overlays, support, resistance and invalidation levels to manage confirmation and risk.
Price Chart
IMVT · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-09
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$8.4B
Company size
EV
$7.4B
Debt-adjusted value
P/E
-16.5
Not meaningful
P/B
8.5
Premium
P/FCF
-20.5
Not meaningful
FCF Yield
-4.88%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Healthy
⚖
Balance Sheet
Strong
📈 Net Income
-110.64M
≈ Insufficient
🧮 EPS (Basic)
-0.61
≈ Insufficient
IMMUNOVANT, INC.
Related Opportunities